Detailed Information
Cited 50 time in 
Cited 56 time in 
Cited 56 time in
Metadata Downloads
AMP-activated protein kinase suppresses the expression of LXR/SREBP-1 signaling-induced ANGPTL8 in HepG2 cells
- Authors
- Lee J.[Lee J.]; Hong S.-W.[Hong S.-W.]; Park S.E.[Park S.E.]; Rhee E.-J.[Rhee E.-J.]; Park C.-Y.[Park C.-Y.]; Oh K.-W.[Oh K.-W.]; Park S.-W.[Park S.-W.]; Lee W.-Y.[Lee W.-Y.]
- Issue Date
- 2015
- Keywords
- ANGPTL8; LXR; SREBP-1; AMPK; PPAR alpha; Hepatocytes
- Citation
- Molecular and Cellular Endocrinology, v.414, pp.148 - 155
- Journal Title
- Molecular and Cellular Endocrinology
- Volume
- 414
- Start Page
- 148
- End Page
- 155
- Abstract
- ANGPTL8 is a liver-derived secretory protein that leads to elevated serum triglyceride and the level of circulating ANGPTL8 is strongly associated with obesity and diabetes. Here we investigated the mechanisms of activation and inhibition of ANGPTL8 expression in hepatocytes.The expression of ANGPTL8 was significantly increased in HepG2 cells exposed to palmitic acid, tunicamycin, or T0901317, and was reversed in cells treated with AICAR. Palmitic acid, tunicamycin, and T0901317 increased LXRα and SREBP-1c mRNA expression. The inhibitory effect of AICAR on the expression of T0901317-induced ANGPTL8 was most strongly evident in cells that were transfected with SREBP-1 siRNA. AICAR increased phosphorylation of PPARα and the effect of AICAR was not observed in cells treated with PPARα inhibitor. Metformin had a similar effect on ANGPTL8 expression to that of AICAR. These data suggest that AMPK can suppress the expression of LXR/SREBP-1 signal-induced ANGPTL8 in HepG2 cells. © 2015 Elsevier Ireland Ltd.
- Files in This Item
- There are no files associated with this item.
- Appears in
Collections - Medicine > Department of Medicine > 1. Journal Articles
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.